Graft-versus-host Disease Prophylaxis With Abatacept Reduces Severe Acute Graft-versus-host Disease in Allogeneic Hematopoietic Stem Cell Transplant for Beta-thalassemia Major With Busulfan, Fludarabine, and Thiotepa.
Transplantation
; 105(4): 891-896, 2021 04 01.
Article
in En
| MEDLINE
| ID: mdl-32467478
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vidarabine
/
Busulfan
/
Thiotepa
/
Beta-Thalassemia
/
Hematopoietic Stem Cell Transplantation
/
Transplantation Conditioning
/
Abatacept
/
Graft vs Host Disease
/
Immunosuppressive Agents
Type of study:
Diagnostic_studies
/
Observational_studies
/
Risk_factors_studies
Limits:
Adolescent
/
Child
/
Child, preschool
/
Female
/
Humans
/
Infant
/
Male
Language:
En
Journal:
Transplantation
Year:
2021
Type:
Article